The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Vera Therapeutics Inc (NASDAQ: VERA) closed at $21.39 in the last session, up 1.33% from day before closing price of $21.11. In other words, the price has increased by $1.33 from its previous closing price. On the day, 1.08 million shares were traded. VERA stock price reached its highest trading level at $21.98 during the session, while it also had its lowest trading level at $21.34.
Ratios:
We take a closer look at VERA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 25.58 and its Current Ratio is at 25.58. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 04, 2025, initiated with a Outperform rating and assigned the stock a target price of $49.
On January 28, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $58.
On November 21, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $70.Wells Fargo initiated its Overweight rating on November 21, 2024, with a $70 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 21 ’25 when Fordyce Marshall sold 10,613 shares for $27.89 per share. The transaction valued at 296,032 led to the insider holds 213,740 shares of the business.
Fordyce Marshall sold 9,075 shares of VERA for $250,882 on Feb 26 ’25. The PRESIDENT AND CEO now owns 204,665 shares after completing the transaction at $27.65 per share. On Feb 26 ’25, another insider, MARSHALL FORDYCE, who serves as the Director of the company, bought 9,075 shares for $27.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 1364076672 and an Enterprise Value of 777361920.
Stock Price History:
The Beta on a monthly basis for VERA is 1.32, which has changed by -0.4645807 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is -19.43%, while the 200-Day Moving Average is calculated to be -42.24%.
Shares Statistics:
According to the various share statistics, VERA traded on average about 941.81K shares per day over the past 3-months and 1003470 shares per day over the past 10 days. A total of 63.56M shares are outstanding, with a floating share count of 48.96M. Insiders hold about 23.22% of the company’s shares, while institutions hold 91.36% stake in the company. Shares short for VERA as of 1743379200 were 6541492 with a Short Ratio of 6.95, compared to 1740700800 on 7797445. Therefore, it implies a Short% of Shares Outstanding of 6541492 and a Short% of Float of 11.82.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
